Peptide Receptor Radionuclide Therapy (PRRT) in a Patient Affected by Metastatic Breast Cancer with Neuroendocrine Differentiation.

ABSTRACT:

Background

Breast cancer (BC) is the most frequent cancer in European women with nearly 30% of the patients eventually developing metastases. Neuroendocrine differentiation is a rare event, but overexpression of somatostatin receptors in BC has been reported in many studies.

Case report

A patient with liver metastases from BC was treated with peptide receptor radionuclide therapy (PRRT). Computed tomography scan and biochemical examinations showed a clear response to radionuclide therapy.

Conclusion

PRRT may be useful in metastatic BC patients.

SUBMITTER: Savelli G 

PROVIDER: S-EPMC3518936 | biostudies-literature |

REPOSITORIES: biostudies-literature